A Clinical Trial To Study The Effect Of V-Guard (Spatika) Vaginal Pessary In The Management Of White Discharge

Open Randomized Controlled Clinical Trial OF V-Guard (Spatika) Vaginal Pessary In Shwetpradara With Special Reference To Candidiasis Albicans - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061324

Enrollment

Registered

2024-01-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N889- Noninflammatory disorder of cervixuteri, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 All married cases between the age of 20-upto the age of menopause complaining of Shwetapradara 2 Patient confimed by KOH test 3 Cases irrespective of Socio economical status, religion, occupation is included 4 Candidiasis albicans with DM 5 Candidiasis albicans with cervical erotion

Exclusion criteria

Exclusion criteria: 1 Unmarried Female patients 2 Per vaginal white discharge other than candidiasis albicans cervical or uterine malignancy pregnant women 3 Cervical polyp

Design outcomes

Primary

Measure	Time frame
To Evaluate The Efficacy Of V Guard Vaginal Pessary Spatika In ShwetpradaraTimepoint: 4 Weeks	—

Secondary

Measure	Time frame
To Review The Symptoms Of Shwetpradara From Ayurvedic Literature To Review The Candidiasis Albicans According To Modern Timepoint: 4 Weeks	—

Countries

India

Contacts

Public ContactDr Tinku Ganesh Khalache

Hon Shri Annasaheb Dange Ayueved Medical College Post Graduate Research Center Ashta

tinkuganeshkhalache@gmail.com9423041730

Outcome results